Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Effects on fertility

Description of key information

A Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test with triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane (CAS 51851-37-7) was  included to this dossier for information only. The study was conducted according to the appropriate OECD Test Guideline 422 and in compliance with GLP. No adverse effects were observed on male and female fertility or fetus development at any dose tested.

Effect on fertility: via oral route
Endpoint conclusion:
no study available
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

It is considered not to be either ethical or technically feasible to perform reproductive toxicity testing with [2-(perfluorohexyl)ethyl]dichloro(methyl)silane by any route of exposure at toxicologically relevant doses or concentrations due to its known corrosive properties.

Data on the structural analogue [2-(perfluorohexyl)ethyl]triethoxysilane are also available and they are included as supporting information but they are not considered further due to the fact that corrosion is the predominant effect and that oral exposure is not relevant to humans. In the Combined Repeated Dose Oral Toxicity Study with the Reproduction / Developmental Toxicity Screening Test, conducted according to an appropriate OECD test guideline and in compliance with GLP,  the reported NOAEL value for reproductive toxicity for [2-(perfluorohexyl)ethyl]triethoxysilane was ≥125 mg/kg bw/day (the highest dose tested; Eurofins, 2017).

Effects on developmental toxicity

Description of key information

A Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test with triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane (CAS 51851-37-7) was  included to this dossier for information only. The study was conducted according to the appropriate OECD Test Guideline 422 and in compliance with GLP. No adverse effects were observed on male and female fertility or fetus development at any dose tested.

Effect on developmental toxicity: via oral route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

It is considered not to be either ethical or technically feasible to perform developmental toxicity testing with [2-(perfluorohexyl)ethyl]dichloro(methyl)silane by any route of exposure at toxicologically relevant doses or concentrations due to its known corrosive properties.

Data on the structural analogue [2-(perfluorohexyl)ethyl]triethoxysilane are available and are included as supporting information but they are not considered further due to the fact that corrosion is the predominant effect and that oral exposure is not relevant to humans. In this Combined Repeated Dose Oral Toxicity Study with the Reproduction / Developmental Toxicity Screening Test, conducted according to an appropriate OECD test guideline and in compliance with GLP,  the reported NOAEL value for developmental toxicity for [2-(perfluorohexyl)ethyl]triethoxysilane was ≥125 mg/kg bw/day (the highest dose tested; Eurofins, 2017).

Justification for classification or non-classification

The available information on hydrogen chloride indicates that [2-(perfluorohexyl)ethyl]dichloro(methyl)silane does not require classification for reproductive or developmental toxicity according to Regulation (EC) No. 1272/2008.

Additional information